ERBB2 and breast carcinoma: In a mouse model of HER2-positive breast cancer, TAMs were found to orchestrate breast cancer dissemination during very early stages by dismantling E-cadherin junctions, ultimately fueling breast cancer progression and late stage metastasis [11].